Efficacy and Safety Trial of Conbercept Intravitreal Injection for Neovascular AMD (PANDA-2)
Public ClinicalTrials.gov record NCT03630952. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Double-Masked, Randomized, Dose-Ranging Trial to Evaluate the Efficacy and Safety of Conbercept Intravitreal Injection in Subjects With Neovascular Age-Related Macular Degeneration (AMD) (PANDA-2)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this clinical study is to evaluate the efficacy and safety of two different levels of conbercept intravitreal (IVT) injection as compared to the approved vascular endothelial growth factor (VEGF) antagonist active control, aflibercept intravitreal injection (2.0 mg/eye, Eylea®), in subjects with neovascular AMD.
Study identification
- NCT ID
- NCT03630952
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,157 participants
Conditions and interventions
Conditions
Interventions
- 0.5 mg Conbercept Intravitreal Injection Biological
- 1.0 mg Conbercept Intravitreal Injection Biological
- 2.0 mg Aflibercept Intravitreal Injection Biological
Biological
Eligibility (public fields only)
- Age range
- 50 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 21, 2018 (Actual)
- Primary completion
- Sep 10, 2020 (Actual)
- Completion
- May 19, 2021 (Actual)
- Last update posted
- Jun 23, 2021
2018 – 2021
United States locations
- U.S. sites
- 69
- U.S. states
- 29
- U.S. cities
- 64
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Kanghong Investigative Site | Phoenix | Arizona | 85020 | — |
| Kanghong Investigative Site | Phoenix | Arizona | 85021 | — |
| Kanghong Investigative Site | Springdale | Arkansas | 72762 | — |
| Kanghong Investigative Site | Arcadia | California | 91006 | — |
| Kanghong Investigative Site | Arcadia | California | 91007 | — |
| Kanghong Investigative Site | Bakersfield | California | 93309 | — |
| Kanghong Investigative Site | Encino | California | 91436 | — |
| Kanghong Investigative Site | Glendale | California | 91203 | — |
| Kanghong Investigative Site | Glendora | California | 91741 | — |
| Kanghong Investigative Site | Huntington Beach | California | 92647 | — |
| Kanghong Investigative Site | Pasadena | California | 91107 | — |
| Kanghong Investigative Site | Poway | California | 92064 | — |
| Kanghong Investigative Site | Redlands | California | 92373 | — |
| Kanghong Investigative Site | Redlands | California | 92374 | — |
| Kanghong Investigative Site | Riverside | California | 92505 | — |
| Kanghong Investigative Site | San Francisco | California | 94109 | — |
| Kanghong Investigative Site | Santa Barbara | California | 93013 | — |
| Kanghong Investigative Site | Colorado Springs | Colorado | 80909 | — |
| Kanghong Investigative Site | Waterford | Connecticut | 06385 | — |
| Kanghong Investigative Site | Boynton Beach | Florida | 33426 | — |
| Kanghong Investigative Site | Bradenton | Florida | 34209 | — |
| Kanghong Investigative Site | Miami | Florida | 33126 | — |
| Kanghong Investigative Site | Miami | Florida | 33143 | — |
| Kanghong Investigative Site | Stuart | Florida | 34994 | — |
| Kanghong Investigative Site | Winter Haven | Florida | 33880 | — |
| Kanghong Investigative Site | Atlanta | Georgia | 30328 | — |
| Kanghong Investigative Site | Augusta | Georgia | 30909 | — |
| Kanghong Investigative Site | Marietta | Georgia | 30060 | — |
| Kanghong Investigative Site | Elmhurst | Illinois | 60126 | — |
| Kanghong Investigative Site | Indianapolis | Indiana | 46290 | — |
| Kanghong Investigative Site | New Albany | Indiana | 47150 | — |
| Kanghong Investigative Site | Leawood | Kansas | 66211 | — |
| Kanghong Investigative Site | Springfield | Massachusetts | 01107 | — |
| Kanghong Investigative Site | Grand Rapids | Michigan | 49546 | — |
| Kanghong Investigative Site | Traverse City | Michigan | 49686 | — |
| Kanghong Investigative Site | St Louis | Missouri | 63128 | — |
| Kanghong Investigative Site | Reno | Nevada | 89502 | — |
| Kanghong Investigative Site | Northfield | New Jersey | 08205 | — |
| Kanghong Investigative Site | Teaneck | New Jersey | 07666 | — |
| Kanghong Investigative Site | Albuquerque | New Mexico | 87109 | — |
| Kanghong Investigative Site | Brooklyn | New York | 11201 | — |
| Kanghong Investigative Site | Great Neck | New York | 11021 | — |
| Kanghong Investigative Site | Liverpool | New York | 13088 | — |
| Kanghong Investigative Site | Shirley | New York | 11967 | — |
| Kanghong Investigative Site | Asheville | North Carolina | 28803 | — |
| Kanghong Investigative Site | Winston-Salem | North Carolina | 27157 | — |
| Kanghong Investigative Site | Youngstown | Ohio | 44505 | — |
| Kanghong Investigative Site | Oklahoma City | Oklahoma | 73104 | — |
| Kanghong Investigative Site | Medford | Oregon | 97504 | — |
| Kanghong Investigative Site | Portland | Oregon | 97225 | — |
| Kanghong Investigative Site | Springfield | Oregon | 97477 | — |
| Kanghong Investigative Site | Camp Hill | Pennsylvania | 17011 | — |
| Kanghong Investigative Site | Kingston | Pennsylvania | 18704 | — |
| Kanghong Investigative Site | Ladson | South Carolina | 29456 | — |
| Kanghong Investigative Site | Rapid City | South Dakota | 57701 | — |
| Kanghong Investigative Site | Arlington | Texas | 76012 | — |
| Kanghong Investigative Site | Austin | Texas | 78705 | — |
| Kanghong Investigative Site | Austin | Texas | 78731 | — |
| Kanghong Investigative Site | Bellaire | Texas | 77401 | — |
| Kanghong Investigative Site | Dallas | Texas | 75231 | — |
| Kanghong Investigative Site | Fort Worth | Texas | 76102 | — |
| Kanghong Investigative Site | Kingwood | Texas | 77339 | — |
| Kanghong Investigative Site | McAllen | Texas | 78503 | — |
| Kanghong Investigative Site | Midland | Texas | 79706 | — |
| Kanghong Investigative Site | Temple | Texas | 76502 | — |
| Kanghong Investigative Site | Salt Lake City | Utah | 84107 | — |
| Kanghong Investigative Site | Burlington | Vermont | 05401 | — |
| Kanghong Investigative Site | Charlottesville | Virginia | 22903 | — |
| Kanghong Investigative Site | Bellevue | Washington | 98004 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 85 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03630952, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 23, 2021 · Synced Oct 30, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03630952 live on ClinicalTrials.gov.